Back to Search Start Over

Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes.

Authors :
Zhang C
Ou Q
Gu Y
Cheng G
Du R
Yuan L
Cordiner RL
Kang D
Zhang J
Huang Q
Yu C
Kang L
Wang X
Sun X
Mo X
Tian H
Pearson ER
Meng W
Li S
Source :
Diabetes, metabolic syndrome and obesity : targets and therapy [Diabetes Metab Syndr Obes] 2019 Dec 31; Vol. 12, pp. 2819-2828. Date of Electronic Publication: 2019 Dec 31 (Print Publication: 2019).
Publication Year :
2019

Abstract

Aim: To investigate the count of circulating tissue factor-positive (TF <superscript>+</superscript> ) procoagulant microparticles (MPs) in patients with type 1 diabetes mellitus (T1DM).<br />Methods: This case-control study included patients with T1DM and age and sex-matched healthy volunteers. The counts of phosphatidylserine-positive (PS <superscript>+</superscript> ) MPs and TF <superscript>+</superscript> PS <superscript>+</superscript> MPs and the subgroups derived from different cell types were measured in the peripheral blood sample of the two groups using multicolor flow cytometric assay. We compared the counts of each MP between groups as well as the ratio of the TF <superscript>+</superscript> PS <superscript>+</superscript> MPs and PS <superscript>+</superscript> MPs (TF <superscript>+</superscript> PS <superscript>+</superscript> MPs/PS <superscript>+</superscript> MPs).<br />Results: We recruited 36 patients with T1DM and 36 matched healthy controls. Compared with healthy volunteers, PS <superscript>+</superscript> MPs, TF <superscript>+</superscript> PS <superscript>+</superscript> MPs and TF <superscript>+</superscript> PS <superscript>+</superscript> MPs/PS <superscript>+</superscript> MPs were elevated in patients with T1DM (PS <superscript>+</superscript> MPs: 1078.5 ± 158.08 vs 686.84 ± 122.04/μL, P <0.001; TF <superscript>+</superscript> PS <superscript>+</superscript> MPs: 202.10 ± 47.47 vs 108.33 ± 29.42/μL, P <0.001; and TF <superscript>+</superscript> PS <superscript>+</superscript> MPs/PS <superscript>+</superscript> MPs: 0.16 ± 0.04 vs 0.19 ± 0.05, P = 0.004), mostly derived from platelet, lymphocytes and endothelial cells. In the subgroup analysis, the counts of total and platelet TF <superscript>+</superscript> PS <superscript>+</superscript> MPs were increased in patients with diabetic retinopathy (DR) and with higher HbA1c, respectively.<br />Conclusion: Circulating TF <superscript>+</superscript> PS <superscript>+</superscript> MPs and those derived from platelet, lymphocytes and endothelial cells were elevated in patients with T1DM.<br />Competing Interests: Professor Ruth LM Cordiner reports Rising Star Educational Award from International Diabetes Center, Co-Sponsored by Sanofi. The authors report no other conflicts of interest in this work.<br /> (© 2019 Zhang et al.)

Details

Language :
English
ISSN :
1178-7007
Volume :
12
Database :
MEDLINE
Journal :
Diabetes, metabolic syndrome and obesity : targets and therapy
Publication Type :
Academic Journal
Accession number :
32021345
Full Text :
https://doi.org/10.2147/DMSO.S225761